Sheryl Orr counsels clients in the structuring and negotiation of US and cross-border mergers, acquisitions, dispositions, carve-out transactions, joint ventures, complex internal reorganizations, and other strategic business transactions. Sheryl’s experience representing both strategic and financial buyers and sellers in the financial services and life sciences industries enables her to help her clients successfully achieve their business goals while navigating and solving structuring issues, any regulatory approval landscape and potential customer, employee and third party consents. She is a co-leader of the firm’s technology industry team, the co-leader of the firm’s corporate and business transactions practice in New York, and the former co-leader of the firm’s global mergers and acquisitions practice.
Her clients include broker-dealers, investment advisers, asset managers, trust companies, and other financial institutions, as well as both branded and generic pharmaceutical companies and private equity firms.
Recommended, Media, technology and telecoms: Technology transactions, The Legal 500 US (2022–2024)
Recommended, M&A/corporate and commercial: M&A: large deals ($1bn+), The Legal 500 US (2020, 2021)
Recommended, Media, technology and telecoms: Fintech, The Legal 500 US (2020, 2021)
Ranked, Corporate/M&A, New York, Chambers USA (2019)
Rising Star, Mergers & Acquisitions, New York, Super Lawyers (2011–2013)
Editor-in-chief, College of William and Mary Journal of Women and the Law
Member, Financial Women’s Association